Abstract
Radioactive iodine has been used to treat over 300,000 thyrotoxic patients since 1946. This paper reviews the knowledge gained in the past 23 years about the efficacy and safety of 131I therapy for thyrotoxicosis. Modifications with reference to case selection, dosage, and follow‐up are discussed.